SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB

Corporate Breaking News

Home : SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB

Nov 04 2022	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Y-mAbs Therapeutics, Inc. ("Y-mAbs" or the "Company") (NASDAQ: YMAB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The...


Source:https://www.prnewswire.com:443/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-y-mabs-therapeutics-inc---ymab-301668650.html

Related News
» SPORTOFI - A NEW WEB 3 BLOCKBUSTER IN THE NEXT-LEVEL GAMEFI GENERATION » Merck KGaA, Darmstadt, Allemagne et p-Chip Corporation collaborent pour améliorer la confiance et la transparence dans les chaînes de valeur industrielles pilotées par la technologie Machine-to-Machine